Cargando…
A regulatory challenge for natural language processing (NLP)‐based tools such as ChatGPT to be legally used for healthcare decisions. Where are we now?
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405238/ https://www.ncbi.nlm.nih.gov/pubmed/37548259 http://dx.doi.org/10.1002/ctm2.1362 |
_version_ | 1785085483998511104 |
---|---|
author | Baumgartner, Christian Baumgartner, Daniela |
author_facet | Baumgartner, Christian Baumgartner, Daniela |
author_sort | Baumgartner, Christian |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10405238 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-104052382023-08-08 A regulatory challenge for natural language processing (NLP)‐based tools such as ChatGPT to be legally used for healthcare decisions. Where are we now? Baumgartner, Christian Baumgartner, Daniela Clin Transl Med Commentary John Wiley and Sons Inc. 2023-08-07 /pmc/articles/PMC10405238/ /pubmed/37548259 http://dx.doi.org/10.1002/ctm2.1362 Text en © 2023 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Commentary Baumgartner, Christian Baumgartner, Daniela A regulatory challenge for natural language processing (NLP)‐based tools such as ChatGPT to be legally used for healthcare decisions. Where are we now? |
title | A regulatory challenge for natural language processing (NLP)‐based tools such as ChatGPT to be legally used for healthcare decisions. Where are we now? |
title_full | A regulatory challenge for natural language processing (NLP)‐based tools such as ChatGPT to be legally used for healthcare decisions. Where are we now? |
title_fullStr | A regulatory challenge for natural language processing (NLP)‐based tools such as ChatGPT to be legally used for healthcare decisions. Where are we now? |
title_full_unstemmed | A regulatory challenge for natural language processing (NLP)‐based tools such as ChatGPT to be legally used for healthcare decisions. Where are we now? |
title_short | A regulatory challenge for natural language processing (NLP)‐based tools such as ChatGPT to be legally used for healthcare decisions. Where are we now? |
title_sort | regulatory challenge for natural language processing (nlp)‐based tools such as chatgpt to be legally used for healthcare decisions. where are we now? |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405238/ https://www.ncbi.nlm.nih.gov/pubmed/37548259 http://dx.doi.org/10.1002/ctm2.1362 |
work_keys_str_mv | AT baumgartnerchristian aregulatorychallengefornaturallanguageprocessingnlpbasedtoolssuchaschatgpttobelegallyusedforhealthcaredecisionswherearewenow AT baumgartnerdaniela aregulatorychallengefornaturallanguageprocessingnlpbasedtoolssuchaschatgpttobelegallyusedforhealthcaredecisionswherearewenow AT baumgartnerchristian regulatorychallengefornaturallanguageprocessingnlpbasedtoolssuchaschatgpttobelegallyusedforhealthcaredecisionswherearewenow AT baumgartnerdaniela regulatorychallengefornaturallanguageprocessingnlpbasedtoolssuchaschatgpttobelegallyusedforhealthcaredecisionswherearewenow |